104
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma

, , , , , , , , & show all
Pages 5373-5381 | Published online: 05 Nov 2018

References

  • StreetJMKoritzinskyEHGlispieDMStarRAYuenPSUrine Exosomes: An Emerging Trove of BiomarkersAdv Clin Chem20177810312228057185
  • ValadiHEkströmKBossiosASjöstrandMLeeJJLötvallJOExosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNat Cell Biol20079665465917486113
  • SunWLuoJDJiangHDuanDDTumor exosomes: a double-edged sword in cancer therapyActa Pharmacol Sin201839453454129542685
  • YangLWuXHWangDLuoCLChenLXBladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitroMol Med Rep2013841272127823969721
  • BeckhamCJOlsenJYinPNBladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progressionJ Urol2014192258359224530986
  • AfsharpadMNowrooziMRMobasheriMBCancer-testis antigens as new candidate diagnostic biomarkers for transitional cell carcinoma of bladderPathol Oncol Res2017
  • EsfandiaryAGhafouri-FardSNew York esophageal squamous cell carcinoma-1 and cancer immunotherapyImmunotherapy20157441143925917631
  • EsfandiaryAGhafouri-FardSMAGE-A3: an immunogenic target used in clinical practiceImmunotherapy20157668370426100270
  • LeiblichARecent Developments in the Search for Urinary Biomarkers in Bladder CancerCurr Urol Rep2017181210029130146
  • AndreFSchartzNEMovassaghMMalignant effusions and immunogenic tumour-derived exosomesLancet2002360932929530512147373
  • Ghafouri-FardSGhafouri-FardSImmunotherapy in nonmelanoma skin cancerImmunotherapy20124549951022642333
  • RajagopalanKMooneySMParekhNGetzenbergRHKulkarniPA majority of the cancer/testis antigens are intrinsically disordered proteinsJ Cell Biochem2011112113256326721748782
  • FradetYPicardVBergeronALarueHCancer-testis antigen expression in bladder cancerProg Urol2005156 Suppl 11303131316734221
  • YangBWuJMaddodiNMaYSetaluriVLongleyBJEpigenetic control of MAGE gene expression by the KIT tyrosine kinaseJ Invest Dermatol200712792123212817495964
  • OsterlundCTöhönenVForslundKONordqvistKMage-b4, a novel melanoma antigen (MAGE) gene specifically expressed during germ cell differentiationCancer Res20006041054106110706124
  • TaniuraHTaniguchiNHaraMYoshikawaKNecdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1J Biol Chem199827327207289422723
  • KuwakoKTaniuraHYoshikawaKNecdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptorJ Biol Chem200427931703171214593116
  • DavisJNWojnoKJDaignaultSElevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancerCancer Res20066624118971190617178887
  • LinZRWangMYHeSYCaiZMHuangWRTACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancerCell Death Dis2018927229358577
  • van AalderenMCYapiciÜvan der PolJAPolyomavirus BK in the pathogenesis of bladder cancerNeth J Med2013711262823412820
  • Sánchez-CarbayoMHerreroEMegíasJMiraASoriaFEvaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladderBJU Int199984670671310510120
  • MansouriKMostafieARezazadehDShahlaeiMModarressiMHNew function of TSGA10 gene in angiogenesis and tumor metastasis: a response to a challengeable paradoxHum Mol Genet201625223324426573430
  • SzymańskaBSawickaEGuzikAZdrojowyRDługoszAThe Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from CarcinogensBiomed Res Int2017201796431391128929116